englishslovensky
  • Duraj Jozef, Hunáková Ľubica, Boďo Juraj, Jakubíková Jana, Chovancová Jana, Sedlák Ján: Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitiveand cisplatin-resistant cells. Neoplasma 56, p. 209-215, 2009
  • Matúšková Miroslava, Hlubinová Kristína, Pastoráková Andrea, Hunáková Ľubica, Altanerová Veronika, Altaner Čestmír, Kučerová Lucia: HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Letters 290, p. 58-67, 2010  [PubMed]
  • Hunáková Ľubica, Sedláková Oľga, Cholujová Dana, Gronesová Paulína, Duraj Jozef, Sedlák Ján: Modulation of markers associated with aggressive phenotype in MDA-MB- 231 breast carcinoma cells by sulforaphane.. Neoplasma 6, p. 548-556, 2009
  • Stehlik Peter, Pauliková H, Hunáková Ľubica: Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin. Neoplasma 57, p. 473-481, 2010
  • Ondrušová Martina, Ondruš Dalibor, Muzik Jan, Hunáková Ľubica, Hes O., Karabínoš Juraj, Friedova L.: Trends in the Kidney Cancer Incidence and Mortality in the Slovak and Czech Republics in 1980-2005 – in the Context of an International Comparison. Neoplasma 58, p. 165-171, 2011

Valid HTML 4.01 Transitional